Interleukin-17A and interleukin-23 in morphea

Archives of Medical Science

Volumn 8, Issue 6, 2012, Pages 1089-1095

  Danczak Pazdrowska, Aleksandra ^a   Kowalczyk, Michał ^a   Szramka Pawlak, Beata ^a   Gornowicz Porowska, Justyna ^a   Szewczyk, Aleksandra ^a   Silny, Wojciech ^a   Olewicz Gawlik, Anna ^a   Molinska Glura, Marta ^a   Zaba, Ryszard ^a   Hrycaj, Paweł ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Autoimmune diseases; Interleukin 17; Interleukin 23; Morphea; Scleroderma

Indexed keywords

ANTINUCLEAR ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 23; RNA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; MORPHEA; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SKIN BIOPSY; TISSUE INJURY;

EID: 84873157251     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.32421     Document Type: Article

References (29)

1. Peterson LS, Nelson AM, Su W P D. Classification of morphea (localized scleroderma). Mayo Clin Proc 1995;70:1068-76.
2. Takehara K, Sato S. Localized scleroderma is an autoimmune disorder. Rheumatology 2005;44:274-9. (Pubitemid 40361280)
3. Kreuter A, Krieg T, Worm M, et al. Diagnosis and therapy of localized scleroderma. J Deutsch Dermatol Ges 2009;7 suppl. 6:S1-14.
4. Reich A, Heisig M, Baran E. Werner syndrome - a premature aging syndrome that can mimic scleroderma. Postep Derm Alergol 2010;27:490-4.
5. Nedoszytko B. Genetically determined syndromes associated with premature aging. Postep Derm Alergol 2010;27:282-90.
6. Akimoto S, Ishikawa O, Yokoyama Y., Amano H, Miya-Chi Y. Generalized morphea with vascular involvement. A case report and disaccharide analysis of the skin glycos - amino glycans. Acta Derm Venereol 1996;76:141-3.
7. Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G. Endothelial cell apoptosis is a primary pathogenic event underlying skin lesions in avian and human scleroderma. J Clin Invest 1996;98:785-92. (Pubitemid 26349184)
8. Xie Y, Zhang X, Wakasugi S, Makino T, Inoue Y, Ihn H. Immunohistochemical characterization of the cellular infiltrate in localized scleroderma. Int J Dermatol 2008;47:438-42. (Pubitemid 351560306)
9. Dziankowska-Bartkowiak B, Gerlicz-Kowalczuk Z, Wasz-Czykowska E. Angiogenin and SDF-1alpha serum concentration in patients with systemie sclerosis In relation to clinical status. Arch Med Sci 2011;7:92-96.
10. Kurasawa K, Hirose K, Sano H, et al. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheumatism 2000;43:2455-63.
11. Alexandrakis MG, Pappa CA, Miyakis S, et al. Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma. Eur J Int Med 2006;17:412-6. (Pubitemid 44572138)
12. Murata M, Fujimoto M, Matsushita T, et al. Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease? J Dermatol Sci 2008;50:240-2.
13. Radstake T R D J, Van Bon L, Broen J, et al. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and INFgamma distinguishes SSc Phenotypes. PLoS ONE 2009;4:e5903.
14. Pappu R, Ramirez-Carrozzi V, Ota N, Ouyang W, Hu Y. The IL-17 family cytokines in immunity and disease. J Clin Immunol 2010;30:185-95.
15. Hemdan N Y A, Birkenmeier G, Wichmann G, et al. Interleukin-17-producing T helper in autoimmunity. Autoimmunity Rev 2010;9:785-92.
16. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010;129:311-21.
17. Numasaki M, Watanabe M, Suzuki T, et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cel lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 2005;175:6177-89. (Pubitemid 41508106)
18. Takahashi H, Numasaki M, Lotze MT, Sasaki H. Interleu-kin-17 enhances bFGF-, HGF-and VEGF-induced growth of vascular endothelial cells. Immunology Letters 2005;98:189-93. (Pubitemid 40602629)
19. Zhu F, Wang Q, Guo C, et al. IL-17 induces apoptosis of vascular endothelial cells - a potential mechanism for human acute coronary syndrome. Clin Immunol 2011;141:152-60.
20. Aggarwal S, Ghilardi N, Xie MH, De Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of intrleukin-17. J Biol Chem 2003;278:1910-4. (Pubitemid 36801431)
21. Costa VS, Mattana T C C, Da Silva M E R. Unregulated IL-23/IL-17 immune response in autoimmune diseases. Diabetes Res Clin Pract 2010;88:222-6.
22. Arkachaisri T, Pino S. Localized scleroderma severity index and global assessment: a pilot study of outcome instruments. J Rheumatol 2008;35:650-7. (Pubitemid 351500061)
23. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987;162:156-9. (Pubitemid 17064313)
24. Pattyn F, Speleman F, De Paepe A, Vandesompele J. RTPrimerDB: the real-time PCR primer and probe database. Nucleic Acids Research 2003;31:122-3. (Pubitemid 36150349)
25. Namysł J, Osmola A, Prokop J. Expression of human endogenous retrovirus sequences in patients with generalised scleroderma and various clinical forms of psoriasis [Polish]. Postep Derm Alergol 2005;22:99-104. (Pubitemid 40716238)
26. Bonnet-Duquennoy M, Abaibou H, Tailhardt M, et al. Study of housekeeping gene expression in human keratinocytes using OLISATM, a long-oligonucleotide microarray and qRT-PCR. Eur J Dermatol 2006;16:136-40.
27. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y. Neutralization of interleukin-17 aggravates dextran sulphate sodium-induced colitis in mice. Clin Immunol 2004;110:55-62. (Pubitemid 38177420)
28. Van Beelen AJ, Teunissen M B M, Kapsenberg ML, De Jong EC. Interleukin-17 in inflammatory skin disorders. Curr Opin Allergy Clin Immunol 2007;7:374-81. (Pubitemid 47415279)
29. Komura K, Fujimoto M, Hasegawa M, et al. Increased serum interleukin 23 in patients with systemic sclerosis. J Rheumatol 2008;35:120-5.